Finemedix Co., Ltd. (KOSDAQ:387570)

Berry Global Group Statistics

Total Valuation

Finemedix has a market cap or net worth of KRW 40.95 billion. The enterprise value is 36.37 billion.

Market Cap	40.95B
Enterprise Value	36.37B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Finemedix has 5.43 million shares outstanding. The number of shares has increased by 3.50% in one year.

Current Share Class	5.43M
Shares Outstanding	5.43M
Shares Change (YoY)	+3.50%
Shares Change (QoQ)	+11.13%
Owned by Insiders (%)	37.29%
Owned by Institutions (%)	n/a
Float	2.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.06
PB Ratio	2.06
P/TBV Ratio	2.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 83.75, with an EV/FCF ratio of -24.25.

EV / Earnings	-66.92
EV / Sales	3.61
EV / EBITDA	83.75
EV / EBIT	n/a
EV / FCF	-24.25

Financial Position

The company has a current ratio of 5.95, with a Debt / Equity ratio of 0.15.

Current Ratio	5.95
Quick Ratio	4.19
Debt / Equity	0.15
Debt / EBITDA	6.70
Debt / FCF	-1.94
Interest Coverage	-4.62

Financial Efficiency

Return on equity (ROE) is -3.34% and return on invested capital (ROIC) is -1.73%.

Return on Equity (ROE)	-3.34%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-1.73%
Return on Capital Employed (ROCE)	-2.42%
Revenue Per Employee	144.08M
Profits Per Employee	-7.76M
Employee Count	70
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-181.71M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	7,672.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.40
Average Volume (20 Days)	42,840

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Finemedix had revenue of KRW 10.09 billion and -543.45 million in losses. Loss per share was -114.05.

Revenue	10.09B
Gross Profit	5.64B
Operating Income	-549.74M
Pretax Income	-725.15M
Net Income	-543.45M
EBITDA	434.21M
EBIT	-549.74M
Loss Per Share	-114.05

Balance Sheet

The company has 7.49 billion in cash and 2.91 billion in debt, giving a net cash position of 4.58 billion or 843.41 per share.

Cash & Cash Equivalents	7.49B
Total Debt	2.91B
Net Cash	4.58B
Net Cash Per Share	843.41
Equity (Book Value)	19.89B
Book Value Per Share	3,662.63
Working Capital	11.86B

Cash Flow

In the last 12 months, operating cash flow was -683.11 million and capital expenditures -816.20 million, giving a free cash flow of -1.50 billion.

Operating Cash Flow	-683.11M
Capital Expenditures	-816.20M
Free Cash Flow	-1.50B
FCF Per Share	-276.10

Margins

Gross margin is 55.97%, with operating and profit margins of -5.45% and -5.39%.

Gross Margin	55.97%
Operating Margin	-5.45%
Pretax Margin	-7.19%
Profit Margin	-5.39%
EBITDA Margin	4.31%
EBIT Margin	-5.45%
FCF Margin	n/a

Dividends & Yields

Finemedix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.50%
Shareholder Yield	n/a
Earnings Yield	-1.33%
FCF Yield	-3.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Finemedix has an Altman Z-Score of 7.07.

Altman Z-Score	7.07
Piotroski F-Score	n/a